ADVANCE OPERATIONAL AGILITY AMID GEOPOLITICAL VOLATILITY AND PRICING PRESSURE: A PHARMA COMMERCIAL CASE STUDY

Geopolitical instability, trade disruption, and global pricing reforms are reshaping pharmaceutical commercialization, challenging companies to protect supply while remaining competitive in Canada. Strengthen end-to-end operational agility across manufacturing and supply functions to respond rapidly to volatility, safeguard margins, and maintain reliable product availability.

Adopt best practice to:

• Align manufacturing capacity, supply network strategy, and inventory positioning to mitigate geopolitical and trade risk
• Redesign governance models to enable faster, data-driven decision-making across commercial operations
• Protect service levels and working capital amid demand variability and pricing pressure
• Reassess sourcing and footprint strategy to strengthen Canadian supply reliability
• Implement performance metrics that balance margin protection, operational resilience, compliance, and service performance

Build a resilient, end-to-end commercial operating model capable of responding to geopolitical and pricing pressures while safeguarding reliable product supply.